All News #Library
Biotech
Iterion Unveils Tegavivint Data For Wnt-Driven Cancers At AACR
13 Apr 2026 //
PR NEWSWIRE
Iterion Therapeutics Expands Clinical Development of Tegavivint
25 Mar 2026 //
PR NEWSWIRE
Iterion Launches Tegavivint Trial in Relapsed Osteosarcoma
10 Feb 2026 //
PR NEWSWIRE

Market Place
Sourcing Support